[HTML][HTML] Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized …
DJ Winston, F Saliba, E Blumberg, M Abouljoud… - American Journal of …, 2012 - Elsevier
Maribavir is an oral benzimidazole riboside with potent in vitro activity against
cytomegalovirus (CMV), including some CMV strains resistant to ganciclovir. In a …
cytomegalovirus (CMV), including some CMV strains resistant to ganciclovir. In a …
Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double …
DJ Winston, F Saliba, E Blumberg… - American Journal of …, 2012 - europepmc.org
Maribavir is an oral benzimidazole riboside with potent in vitro activity against
cytomegalovirus (CMV), including some CMV strains resistant to ganciclovir. In a …
cytomegalovirus (CMV), including some CMV strains resistant to ganciclovir. In a …
Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double …
DJ Winston, F Saliba, E Blumberg… - AMERICAN …, 2012 - biblio.ugent.be
Maribavir is an oral benzimidazole riboside with potent in vitro activity against
cytomegalovirus (CMV), including some CMV strains resistant to ganciclovir. In a …
cytomegalovirus (CMV), including some CMV strains resistant to ganciclovir. In a …
Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized …
DJ Winston, F Saliba, E Blumberg, M Abouljoud… - American Journal of …, 2012 - infona.pl
Maribavir is an oral benzimidazole riboside with potent in vitro activity against
cytomegalovirus (CMV), including some CMV strains resistant to ganciclovir. In a …
cytomegalovirus (CMV), including some CMV strains resistant to ganciclovir. In a …
[引用][C] Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A …
DJ WINSTON, F SALIBA, M NAVASA… - American journal of …, 2012 - pascal-francis.inist.fr
Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of
Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind …
Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind …
Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: A randomized, double …
DJ Winston, F Saliba, E Blumberg… - American Journal of …, 2012 - pure.johnshopkins.edu
Maribavir is an oral benzimidazole riboside with potent in vitro activity against
cytomegalovirus (CMV), including some CMV strains resistant to ganciclovir. In a …
cytomegalovirus (CMV), including some CMV strains resistant to ganciclovir. In a …
Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double …
DJ Winston, F Saliba, E Blumberg… - American Journal of …, 2012 - orbi.uliege.be
Maribavir is an oral benzimidazole riboside with potent in vitro activity against
cytomegalovirus (CMV), including some CMV strains resistant to ganciclovir. In a …
cytomegalovirus (CMV), including some CMV strains resistant to ganciclovir. In a …
Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized …
DJ Winston, F Saliba, E Blumberg… - American Journal of …, 2012 - Wiley Online Library
Maribavir is an oral benzimidazole riboside with potent in vitro activity against
cytomegalovirus (CMV), including some CMV strains resistant to ganciclovir. In a …
cytomegalovirus (CMV), including some CMV strains resistant to ganciclovir. In a …
Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized …
DJ Winston, F Saliba, E Blumberg… - American Journal of …, 2012 - amjtransplant.org
Maribavir is an oral benzimidazole riboside with potent in vitro activity against
cytomegalovirus (CMV), including some CMV strains resistant to ganciclovir. In a …
cytomegalovirus (CMV), including some CMV strains resistant to ganciclovir. In a …
[引用][C] Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A …
DJ Winston, F Saliba, E Blumberg… - American Journal of …, 2012 - cir.nii.ac.jp
Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of
Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind …
Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind …